Search

everythinglearnresearchcommunity

for

Search:↓

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

Organoids created from stem cells are used to model diseases, test drugs, and develop personalized and regenerative medicine.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Dutasteride may help shrink prostate cancer tumors.

Finasteride does not prevent bladder cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Targeting colon cancer stem cells might lead to better treatment results.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Stopping S100A3 activity slows down hair growth in mice.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.